SCHEMBL13637352

SCHEMBL13637352

Cc1ccc(-c2cn3cccc(C(C)O)c3n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.65
NPC1 O15118 8/20 0.65
RAB9A P51151 8/20 0.65
NFKB1 P19838 3/20 0.65
NFKB2 Q00653 3/20 0.65
RELA Q04206 3/20 0.65
GAA P10253 2/20 0.65
KDM4E B2RXH2 7/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
TP53 P04637 4/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
PKM P14618 1/20 0.51
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
DHODH Q02127 1/20 0.47
ALDH1A3 P47895 5/20 0.46
ALDH1A2 O94788 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13643181 0.81 CENPE (0.45) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL5738406 0.80 ALDH1A1 (0.72) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL13183963 0.80 CENPE (0.44) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL14870853 0.80 CENPE (0.44) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL2617328 0.80 CENPE (0.44) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL2617338 0.79 ALDH1A1 (1.00) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL28635183 0.78 NPC1 (0.74) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL14531640 0.77 NPC1 (0.72) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL28642108 0.77 NPC1 (0.72) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL21348767 0.75 ALDH1A1 (0.47) ALDH1A1NPC1RAB9ANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2012-11-08 US disclosed
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. 2009-11-19 US disclosed
US-7504413-B2 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases CYTOKINETICS, INC. (US) 2009-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885NPC1 835/4885RAB9A 1213/4885
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885NPC1 835/4885RAB9A 1213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.